Why the study?
Does enalaprilat improve systolic and diastolic function during low-flow ischemia and reperfusion in hypertrophied and nonhypertrophied rat hearts?
Population
Isolated, red blood cell-perfused isovolumic nonhypertrophied and hypertrophied rat hearts
Comparison
Enalaprilat (2.5 x 10 M final concentration)… vs Untreated nonhypertrophied and hypertrophied rat…
Design
Preclinical
Follow-up
80 minutes
Authors
Loading...
Hypothesis-generating for ACE inhibition in hypertrophied hearts during ischemia; human trials needed before clinical consideration.
Does enalaprilat improve systolic and diastolic function during low-flow ischemia and reperfusion in hypertrophied and nonhypertrophied rat hearts?
Inhibition of cardiac angiotensin converting enzyme with enalaprilat attenuates ischemic diastolic dysfunction in pressure-overload hypertrophied rat hearts.
Eberli et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: